HB420 Alabama 2024 Session

Summary

Primary Sponsor

David FaulknerRepresentative

Republican

Session

Regular Session 2024

Title

Tort Reform, to regulate litigation financing agreements, vicarious liability of employers, proof of medical care expenses, and attorney advertising

Summary

HB420 is a broad tort reform bill that regulates litigation financing, caps noneconomic damages, tightens medical-damage proofs, retools liability and venue rules, strengthens expert testimony standards, regulates attorney advertising, and updates vehicle-seat and safety provisions in Alabama civil cases.

What This Bill Does

It creates the Litigation Financing Safeguards and Transparency Act, requiring disclosure of litigation financing agreements to courts and parties, limiting financiers' payments, prohibiting control of the lawsuit by financiers, and providing penalties for violations. It limits employer liability by allowing written stipulations that an employee acted within the scope of employment to cap damages at vicarious liability, with certain exceptions for egregious conduct, and it reinforces independent contractor presumptions. It imposes a noneconomic-damages cap of $1,000,000 for many post-2024 civil actions, with annual adjustments, and restricts how noneconomic damages are described to juries. It tightens proof and recovery rules for medical expenses, including how payments, plans, letters of protection, and third-party arrangements are treated, and sets limits on recoverable medical damages. It expands expert-testimony standards to more technical fields and requires reliability evidence, while preserving existing medical liability acts. It redefines 'passenger car' to include up to 15 passengers, allows certain seatbelt-related evidence in civil cases, and permits using nonuse of a seatbelt to argue mitigation or causation under specified conditions. It tightens attorney advertising by restricting monetary-award claims to final, actual-recovered amounts that can be verified, with penalties for violations, and regulates change of venue to the location where the underlying facts occurred. It also broadens the duty to disclose foreign involvement in financing and changes venue procedures, effective for actions filed on or after January 1, 2025.

Who It Affects

• Consumers and plaintiffs (including funded consumers) and their attorneys who use or are affected by litigation financing, medical-expense rules, and noneconomic-damages limits.
• Employers, insurers, health-care providers, attorneys, and advertising entities involved in civil actions, who face liability-limitation rules, medical-damages rules, financing disclosures, and advertising restrictions.

Key Provisions

• Litigation Financing Safeguards and Transparency Act: mandatory disclosure of litigation financing agreements to judges, opposing counsel, and parties; limits on financier compensation; financier cannot control case direction; voidable if violated; sanctions for non-disclosure.
• Definitions and scope (§12-21-501 to §12-21-504): clarifies who is a consumer, funded consumer, foreign person/principal, health-care provider, and litigation-financier; sets disclosure and continuing-obligation requirements; outlines transfer restrictions and prohibitions on certain dealings by financiers.
• Financial disclosure and discovery: parties, court, insurers, and known creditors must receive disclosure; class-action considerations and MDL leadership must consider financing existence; ongoing disclosure for amendments.
• Indemnification and sanctions: financiers must indemnify funded consumers against certain frivolous costs or sanctions; void agreements for violations; unfair-deceptive-practice remedies; sanctions for failure to disclose.
• Employer-liability reforms: allows written stipulations to limit employer liability to vicarious liability when the employee acted within the scope of employment; exceptions for wanton/hiring-related conduct under specified conditions; independent-contractor presumptions.
• Venue-change rules: requires transfer of civil actions to the county where the cause of action arose when appropriate; change-of-venue rights are additive to existing rules.
• Noneconomic-damages cap: cap of $1,000,000 on noneconomic damages for post-2024 actions, with inflation-based adjustments in 2028 and every three years; jury not informed of the cap; court must reduce any award exceeding the cap.
• Medical-damages and proof: defines the value and proof of medical expenses, including payments, reimbursements, plans, letters of protection, and accounts receivable; restricts what is recoverable and sets limits; sets rules for future medical expenses and Medicare rates; requires itemized billing data and disclosure of third-party payments.
• Evidence and expert-testimony standards: expands reliability requirements to more technical knowledge; requires demonstration that principles are reliably applied to the case facts; preserves existing medical-liability acts.
• Seat belts and vehicle definitions: redefines 'passenger car' to carry up to 15 passengers; nonuse of seatbelts may be admitted for specific purposes while nonuse cannot automatically prove contributory negligence; seatbelt evidence can be used to prove mitigation or causation in civil actions.
• Attorney advertising: regulates statements about monetary awards obtained; requires results to be final, verifiable, and actually paid to clients; imposes criminal penalties for knowing violations; ensures compliance with professional conduct rules.
• Foreign involvement disclosures: requires disclosure of foreign persons, principals, or sovereign wealth funds with ties to litigation financing when applicable; includes findings for discovery in civil actions.

AI-generated summary using openai/gpt-5-nano on Feb 22, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Civil Procedure